Skip to content
NewsBlazeIN – Lifestyle
Author:
Erasca, Inc.
Erasca Announces Proposed Public Offering of $500 Million of Common Stock
July 13, 2026
Erasca Announces Updated Preliminary Phase 1 Data and Registration-Enabling Plans for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors
July 13, 2026
Erasca to Present at the Jefferies Global Healthcare Conference
May 27, 2026
←
Previous Page
1
2